EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC-ND 4.0

Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial

Yong Min Lee iD, Bobak Bahrami, Duleepa Baranage, Premala Devi Sivagurunathan, Wilson Wong, Montserrat Maria Bausili, Surbhi Agrawal, Jagjit Singh Gilhotra iD, Shane Durkin, David Sia, Dinesh Selva, Stewart Lake iD and 2 more

Clinical & Experimental Ophthalmology · 2024

DOI: 10.1111/ceo.14432 ↗

At a glance

Randomisierte kontrollierte Studie in Clinical & Experimental Ophthalmology, 2024. Written by Yong Min Lee and 13 co-authors. Institution: Ophthalmology Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Major MEDLINE topics: Retinal Perforations, Visual Acuity, Thiophenes, Carbonic Anhydrase Inhibitors. Cited 3 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: University of Adelaide.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

To assess topical dorzolamide as medical therapy for idiopathic full‐thickness macular holes (FTMHs).

Methods

Randomised, double‐blinded, placebo‐controlled, single‐centre clinical trial involving 32 patients with idiopathic small FTMHs (

Subjects

MeSH terms (MEDLINE)

Retinal PerforationsVisual AcuityThiophenesCarbonic Anhydrase InhibitorsSulfonamidesOphthalmic SolutionsTomography, Optical CoherenceHumansDouble-Blind MethodMaleFemaleAgedMiddle AgedTreatment OutcomeVitrectomyAdministration, TopicalFollow-Up StudiesEndotamponade

Author keywords

clinical trialmacular holeplacebotopical dorzolamide

Substances

dorzolamideThiophenesCarbonic Anhydrase InhibitorsSulfonamidesOphthalmic Solutions

Authors and institutions

  • Ophthalmology Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • The University of Adelaide, Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia.
  • Ophthalmology Department, OasisEye Specialists, Kuala Lumpur, Malaysia.
  • Ophthalmology Department, Flinders Medical Centre, Adelaide, South Australia, Australia.
  • Machine Learning Division, Ophthalmic Research Laboratory, University of Adelaide, Adelaide, South Australia, Australia.

ORCID profiles: Yong Min Lee, Jagjit Singh Gilhotra, Stewart Lake, Robert J Casson, Weng Onn Chan

Funding

  • University of Adelaide

Cite

APA

Lee, Y. M., Bahrami, B., Baranage, D., Sivagurunathan, P. D., Wong, W., Bausili, M. M., Agrawal, S., Gilhotra, J. S., Durkin, S., Sia, D., Selva, D., Lake, S., Casson, R. J., & Chan, W. O. (2024). Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14432

Vancouver

Lee YM, Bahrami B, Baranage D, Sivagurunathan PD, Wong W, Bausili MM, et al. Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial. Clinical & Experimental Ophthalmology. 2024. doi:10.1111/ceo.14432

BibTeX
@article{Lee2024,
  author = {Lee, Yong Min and Bahrami, Bobak and Baranage, Duleepa and Sivagurunathan, Premala Devi and Wong, Wilson and Bausili, Montserrat Maria and Agrawal, Surbhi and Gilhotra, Jagjit Singh and Durkin, Shane and Sia, David and Selva, Dinesh and Lake, Stewart and Casson, Robert J and Chan, Weng Onn},
  title = {Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2024},
  doi = {10.1111/ceo.14432}
}
Start for free →